How does Totally plc sell outsourced urgent-care capacity to the NHS and HSE and get paid?
Totally plc ran contracted urgent-care, elective and community services for the UK and Ireland, billing public commissioners per service-delivery and block contracts. Fiscal stress showed: administration in June 2025 after cashflow shortfalls despite growing 2024-25 service volumes and cost inflation.
Totally monetized through activity-based and block contracts with variable margins; fragility came from working-capital gaps and fixed-cost clinics. See operational risks and asset sale details in the Totally SWOT Analysis.
What Does Totally Actually Sell?
Totally plc sells scalable, clinically staffed healthcare capacity: urgent care (NHS 111 telephony, GP out-of-hours, Urgent Treatment Centres), elective insourcing teams (endoscopy, ophthalmology, orthopaedics) and corporate wellbeing/occupational health services-delivering faster patient flow and reduced RTT backlogs for commissioners.
Main products and services
Totally Company supplies clinically staffed service lines rather than buildings: NHS 111 telephony and clinical assessment, GP out-of-hours, Urgent Treatment Centres (UTCs), elective insourcing teams that operate inside NHS theatres (endoscopy, ophthalmology, orthopaedics), plus corporate wellbeing and occupational health via subsidiaries such as Energy Fitness Professionals.
Who it serves
Primary customers are NHS commissioners and hospital trusts needing rapid capacity to cut waiting lists and ease emergency departments; secondary clients include private employers buying occupational health and employee wellbeing programs.
Value delivered to customers
Totally Company reduces Referral to Treatment (RTT) waiting times and ED overcrowding by supplying ready-trained clinical teams and managed service capability; in 2025 contracts reported throughput increases and RTT clearance rates that cut backlog weeks per pathway-commissioners buy time and outcomes, not buildings.
Why customers choose it
Clients pick Totally Company for rapid deployment of specialist staff, predictable per-case pricing, and experience running integrated pathways inside NHS sites; its model is lower capital than building facilities and is positioned as a scalable, operationally focused alternative to traditional private providers. Read more on ownership and structure in this article: Who Owns Totally Company
Totally SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Does Totally Run Day to Day?
Totally Company runs day-to-day as a flexible workforce orchestration engine that matches clinical supply to demand across urgent care and elective insourcing services. Operations combine employed staff, bank clinicians, and subcontracted specialty teams with digital triage and mobile theatre deployment to scale capacity rapidly.
Flexible workforce orchestration
Totally Company coordinates employed clinicians, bank staff, and subcontracted specialty teams on a dynamic schedule. An internal rostering engine reallocates personnel to match demand spikes, theatre availability, and regional waiting list pressure.
Service delivery via triage and mobile teams
Urgent care runs digital triage and telephony hubs that route calls and walk-ins to the right clinical level; elective insourcing teams enter NHS Trust theatres evenings/weekends to perform surgeries and diagnostics using the Trust's infrastructure.
Sourcing and clinical capability
Clinical staff are recruited as employees, bank clinicians (on-call), or via specialist subcontractors. Training, credentialing, and local theatre credential checks are managed centrally to meet NHS governance and indemnity requirements.
Sales and operational channels
Contracts with NHS Trusts and integrated care boards form the primary sales channel; urgent care uses direct patient access via telephony and digital triage, while elective insourcing is delivered through block-booked theatre sessions and service-level agreements.
Key assets and partnerships
Major assets are the rostering/dispatch platform, telephony/triage hubs, and partnerships with NHS Trusts and subcontracted specialist teams. Centralised compliance, procurement, and logistics teams coordinate consumables and theatre kits to avoid capital outlay.
Why the model scales in practice
Using Trust infrastructure for elective insourcing removes the need for new theatres, so capacity scales quickly across regions. Real-time scheduling and bank clinician pools let Totally Company shift resources to areas with the longest waiting lists.
Day-to-day operational summary
Totally Company runs operations by dynamically matching workforce supply to clinical demand via digital triage hubs and mobile elective teams that use NHS Trust facilities; this minimizes capital spend while shortening waiting times.
- Flexible workforce orchestration engine coordinates employed staff, bank clinicians, and subcontractors
- Services delivered through telephony/digital triage for urgent care and mobile elective insourcing for surgeries
- Primary channel: NHS Trust contracts, telephony hubs, and regional scheduling platforms
- Efficiency driver: use of Trust infrastructure plus real-time rostering to redeploy capacity where waiting lists are highest
Recent operational metrics: in 2025 Totally Company reported performing over 12,400 elective procedures via insourcing partnerships and managed 320,000 urgent care contacts through triage hubs year-to-date across the UK and Ireland; average theatre utilisation on insourcing shifts exceeded 78% in H1 2025. For a deeper look at commercial positioning and sales approach see How Totally Company Sells
Totally PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
How Does Money Come In at Totally?
Totally Company earns revenue mainly by contracting with NHS Integrated Care Boards, NHS Trusts, and the HSE in Ireland to deliver urgent and elective care services; payment is largely activity-based, paid per patient episode or procedure. Contracts are multi-year with KPI-linked incentives or penalties, so cash inflows track activity volumes, service mix, and performance versus targets.
Primary revenue from urgent and elective service contracts
Most revenue comes from multi-year frameworks and activity-linked contracts with NHS ICBs, NHS Trusts, and the HSE in Ireland, paid per patient episode or procedure; urgent care historically dominated the mix, driving volume and short-term revenue swings.
Additional revenue: support services and elective shift
Secondary streams include elective surgery programmes, managed services, and ancillary support (diagnostics, staffing), which the business targets to improve margins and reduce reliance on pandemic-era urgent-care surges.
Pricing and monetization: activity tariffs with KPI adjustments
The monetization model is usage-based: activity tariffs pay per episode or procedure, with contract clauses for KPI-linked incentives or penalties (for example four-hour urgent-care targets), and occasional block or hybrid payments in longer-term frameworks.
What most drives revenue: volume and service mix
Revenue is driven by patient volume and the mix between urgent care (high volume, lower margin) and elective services (lower volatility, higher margin); performance vs KPIs also materially affects final payment levels.
How money comes in through activity-linked NHS and HSE contracts
Totally Company converts contracted demand into cash mainly via per-episode activity tariffs under multi-year NHS and HSE frameworks, augmented by elective programmes and KPI adjustments; fiscal variances reflect volume and mix shifts.
- Activity tariffs per patient episode or procedure are the main revenue stream
- Elective services, managed services, and diagnostics act as secondary monetization sources
- Pricing is usage-based with KPI-linked incentives or penalties and occasional hybrid payments
- Volume (patient episodes) and service mix (urgent vs elective) are the strongest revenue drivers
For the fiscal year ending March 31, 2024, Totally plc reported revenue of £106.7 million, down 21 percent from £135.7 million in 2023, reflecting lower urgent-care volumes and a strategic push toward higher-margin elective services; see the History of Totally Company Explained for additional context on contract evolution and prior performance.
Totally SOAR Analysis
- Complete SOAR Analysis
- Effortlessly Communicate Your Business Strategy
- Investor-Ready Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Makes Totally's Model Strong or Fragile?
The Totally Company model is strong because outsourced elective care faced a persistent demand with an England waiting list of about 7.6-7.8 million pathways in 2024-2025, but fragile due to high client concentration, thin margins, and limited balance-sheet resilience that left the public vehicle exposed.
Structural tailwinds that support the model
Permanent demand from long NHS elective waiting lists (roughly 7.6-7.8 million pathways in 2024-2025) creates a durable market for outsourced capacity and maintains revenue opportunities for providers delivering elective and diagnostic services.
Key assets and operational capabilities
Clinical delivery expertise, existing contracting relationships with NHS commissioners, and logistical scale to run elective hubs and pathways kept service delivery viable; these operational strengths underpin How Totally Company works in practice.
Dependencies and concentration risks
Revenue concentration was acute: loss of a single large contract - the £13 million NHS 111 national resilience award lost in February 2025 - demonstrated that one contract loss could trigger insolvency when margins are thin and wage inflation is high.
How durable the model appears in 2025-2026
Operationally durable and necessary for NHS pathway relief, but as a listed public vehicle Totally Company lacked balance-sheet resilience; a potential medical negligence claim > £10 million plus wage inflation pushed the parent beyond its capacity, prompting integration into PHL Group Ltd to secure continuity.
Why the model is strong yet fragile
Totally Company business model worked operationally because outsourced elective care meets persistent NHS demand, but the public structure failed from contract concentration, tight margins, and liability exposure that a single contract loss and large claim made catastrophic.
- Permanent market tailwind: England elective waiting list ~ 7.6-7.8 million
- Most important capability: clinical delivery scale and NHS contracting relationships
- Key constraint: high revenue concentration and thin margins (loss of a £13 million contract in Feb 2025 was decisive)
- Resilience: operationally viable but financially exposed as a public vehicle; integration into PHL Group Ltd was required to continue services
Additional reading on service scope and clients: Who Totally Company Serves
Totally VRIO Analysis
- Covers VRIO Analysis in Details
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
Frequently Asked Questions
Totally sells clinically staffed healthcare capacity, not buildings. Its main services include NHS 111 telephony and clinical assessment, GP out-of-hours care, Urgent Treatment Centres, elective insourcing teams for endoscopy, ophthalmology, and orthopaedics, plus corporate wellbeing and occupational health services.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.